All of our Ottawa Public Health and Parenting in Ottawa web content can now be found in one place. We hope you find the website easier to navigate. It's now as easy to use on your smartphone as your desktop. We expect there will be some issues during the first few weeks we launch, like broken links or PDF documents, so please connect with us and let us know.
To: Ottawa Physicians and Nurse Practitioners
Date: August 20, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Updated PHO AEFI Reporting Form
Dear Colleagues,
In Ontario, Public Health Ontario (PHO) leads the provincial surveillance of adverse events following immunization (AEFIs).
To: Ottawa Physicians and Nurse Practitioners
Date: August 18, 2025
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Rabies Vaccine and Immunoglobulin Supply
Dear Colleagues,
Ontario is experiencing a shortage of rabies vaccines and rabies immunoglobulins (RabIg).
To: Ottawa Physicians and Nurse Practitioners
Date: August 14, 2025
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Confirmed case of measles in Ottawa
Dear Colleagues,
A case of measles has been reported to Ottawa Public Health with potential exposures to the virus for others in the community.
To: Ottawa Physicians and Nurse Practitioners
Date: August 12, 2025
From: Dr. Monir Taha, Associate Medical Officer of Health
Subject: West Nile virus confirmed in Ottawa area mosquitoes
Dear Colleagues,
Ottawa Public Health (OPH) is writing to heighten your awareness of the possibility of illness from West Nile virus (WNV) infection in Ottawa.
To: Ottawa Physicians and Nurse Practitioners
Date: July 29, 2025
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Syphilis testing update and screening recommendations
Public Health Ontario Laboratory (PHOL) has updated its testing approach for syphilis lesion specimens.
To: Ottawa Physicians and Nurse Practitioners
Date: July 16, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Pentacel Vaccine: Important Reminders
Dear Colleagues,
Since the program transition for DTaP-IPV-Hib vaccination from Pediacel® to Pentacel® in July 2024, the manufacturer, Sanofi, has received pharmacovigilance reports of mixing errors with Pentacel®.
To: Ottawa Physicians and Nurse Practitioners
Date: July 10, 2025
From: Dr. Monir Taha, Associate Medical Officer of Health
Subject: Vector-borne disease testing changes at PHOL
Dear Colleagues,
Public Health Ontario Laboratory (PHOL) has recently updated its testing protocols for vector-borne disease testing.
To: Ottawa Physicians and Nurse Practitioners
Date: July 8, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Update on the publicly funded high-risk pneumococcal vaccine program
Dear Colleagues,
The Ministry of Health has provided an update on the publicly funded high-risk pneumococcal vaccine program.
Welcome to the new OttawaPublicHealth.ca
Ottawa Public Health has moved to a refreshed website. During this transition, some links, redirects, documents, pages or display features may be temporarily affected.
Your feedback will help us review and address issues during the stabilization period.
This website uses cookies to enhance usability and provide you with a more personal experience. By using this website, you agree to our use of cookies as explained in our Privacy Policy.